Recent Progress in Tumor Virology Research

Clinical trials have indicated that oncoviruses might be developed as safe and effective anticancer agents. No​vel strategies can be used to facilitate viral evasion of the immune system, the prevention of viral uptake by the liver, and an increased specificity for tumour cells, either at the cell surface or through intracellular restriction.

  • The search for novel tumor viruses
  • Understanding human carcinogenesis by using tumor viruses as experimental tools
  • Defense against the use of viruses in bioterrorism

Related Conference of Recent Progress in Tumor Virology Research

February 24-25, 2020

7th International Congress on Infectious Diseases

Berlin, Germany
April 27-28, 2020

7th Global Congress on Rare Diseases & Orphan Drug

Istanbul, Turkey
June 09-10, 2020

10th European Epidemiology and Public Health Congress

Istanbul, Turkey
July 22-23, 2020

10th World Congress on Rare Diseases and Orphan Drugs

Barcelona, Spain
August 19-20, 2020

European Summit on HIV, STD and STIs

Milan, Italy
September 28-29, 2020

13th Global Infections Conference

September 28-29, 2020

World Congress on Infectious Diseases and Rare Diseases

Osaka, Japan
October 5-6, 2020

12th Euro-Global Conference on Infectious Diseases

Vienna, Austria

Recent Progress in Tumor Virology Research Conference Speakers

Recommended Sessions

Related Journals

Are you interested in